William R. Ferrell

Glasgow, SCT G128TA, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

PAR2 deletion in the osteoblast lineage affords long-term cartilage protection in experimental osteoarthritis.

PAR2 deletion in the osteoblast lineage affords long-term cartilage protection in experimental osteoarthritis.

Journal: Osteoarthritis and cartilage

Published: November 19, 2025

Moderate exercise protects against joint disease in a murine model of osteoarthritis.

Moderate exercise protects against joint disease in a murine model of osteoarthritis.

Journal: Frontiers in physiology

Published: October 09, 2022

Losartan protects endothelium-dependent relaxation in vivo in a murine model of rheumatoid arthritis.

Losartan protects endothelium-dependent relaxation in vivo in a murine model of rheumatoid arthritis.

Journal: European journal of pharmacology

Published: March 26, 2021

Protease activated receptor 2 and matriptase expression in the joints of cats with and without osteoarthritis.

Protease activated receptor 2 and matriptase expression in the joints of cats with and without osteoarthritis.

Journal: Journal of feline medicine and surgery

Published: December 07, 2020

Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.

Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.

Journal: Frontiers in endocrinology

Published: January 25, 2018

Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors.

Endothelium-derived contraction in a model of rheumatoid arthritis is mediated via angiotensin II type 1 receptors.

Journal: Vascular pharmacology

Published: September 07, 2017

The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.

The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover.

Journal: Scientific reports

Published: August 31, 2017

Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology.

Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology.

Journal: Annals of the rheumatic diseases

Published: July 21, 2015

Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial.

Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial.

Journal: Atherosclerosis

Published: December 03, 2014

Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.

Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.

Journal: Maturitas

Published: September 06, 2013

Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function.

Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function.

Journal: Innate immunity

Published: April 23, 2013

Angiotensin II Type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis.

Angiotensin II Type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis.

Journal: Life sciences

Published: January 30, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026